Aegis Therapeutics


Aegis Therapeutics is a San Diego-based drug delivery technology company commercializing its patented drug delivery and drug formulation technologies through strategic partnerships. Intravail drug delivery technology enables the non-invasive, enhanced delivery of a broad range of protein, peptide and non-peptide drugs (up to 30,000 daltons in size) that can currently only be administered by injection. Intravail can be utilized via the oral, buccal, dermal, and intranasal administration routes of drug administration.

Industries

biotechnology

Nr. of Employees

small (1-50)

Aegis Therapeutics

San Diego, California, United States, North America


Patents

Intranasal epinephrine formulations and methods for the treatment of disease

US-12324838-B2

View Details

Intranasal epinephrine formulations and methods for the treatment of disease

US-11918655-B2

View Details

Intranasal epinephrine formulations and methods for the treatment of disease

US-11744895-B2

View Details

Intranasal epinephrine formulations and methods for the treatment of disease

US-11717571-B2

View Details

Intranasal epinephrine formulations and methods for the treatment of disease

US-11191838-B2

View Details

Compositions for drug administration

US-11173209-B2

View Details
View All Patents

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.